Art_of_Discovery_at_the_Garvan_Institute

The Garvan Institute is opening its doors to the public, offering a rare opportunity to see the beauty of medical research through an exhibition of scientific imagery. 

Garvan’s Art of Discovery exhibition is welcoming visitors for National Science Week

Associate Professor Liz Caldon and Dr Sarah Alexandrou

Liz Caldon and Sarah Alexandrou from the Garvan Institute low res.jpg

A team of Garvan scientists has discovered that inactivation of a stress pathway makes ER+ breast cancer cells ignore stress signals, allowing them to evade treatment.

Researchers uncover potential mechanism driving treatment resistance in common breast cancer

GENIE-news_Garvan-Institute.jpg

Study now recruiting participants to better diagnose inborn errors of immunity 

New Garvan study aims to improve early detection of genetic immune disorders

The-AllClear-leadership-team.jpg

The National Breast Cancer Foundation’s landmark investment will drive research focused on stopping breast cancer recurrence.

Historic $25 million grant backs Garvan breast cancer research

230709_Jodie-Ingles_Garvan-Institute

The Elusive Hearts Study will give families with genetically unknown inherited heart conditions a second chance at diagnosis.

Boost for national cardiac genetic testing research program

Hasindu_Gamaarachchi_Garvan

Dr Hasindu Gamaarachchi has been recognised for computational innovations that dramatically reduce the computing power needed for genomic analysis, democratising access to this transformative technology.

Garvan researcher named Eureka Prize finalist for faster genomic analysis

christoper-goodnow_megan-barnet_Garvan-Institute.jpg

Garvan researchers have discovered new pathways that may explain differences in the way people with cancer respond to immunotherapy  

New mechanism found to supercharge the immune system against cancers

Chris Goodnow Garvan Institute

The prestigious award recognises Professor Goodnow’s innovative work on immune system breakdowns and chronic autoimmune disease.

Professor Chris Goodnow honoured with Max Cooper Prize in Immunology

Hetrogenous gene expression in a tumour

Garvan researchers have developed a new AI tool which could be integrated into cancer diagnostics to better inform treatment.

AI tool set to transform characterisation and treatment of cancers

Dr-Louise-Rabbitt_Garvan-Institute.jpg

Experienced veterinarian and facility manager Dr Louise Rabbitt will lead the crucial research facility as current head Dr Jenny Kingham announces retirement.

Dr Louise Rabbitt appointed as new head of Australian BioResources

Professor-Daniel-MacArthur_Garvan-Institute_2025.jpg

Leader of the Centre for Population Genomics internationally recognised for transformative contributions to global genomic research.

Garvan researcher receives prestigious European genomics award

Professor Chris Goodnow and Dr Manu Singh

Chris Goodnow and Manu Singh at the Garvan Institute

Scientists have identified mutated immune cell clones that could point to improved treatment for refractory coeliac disease.

‘Rogue’ immune cells explain why a gluten-free diet fails in some coeliac patients

Dr Rama Dhenni and Professor Tri Phan

Scientists have uncovered why vaccines can elicit a stronger immune response if they are administered in the same arm.

Left or right arm? New research reveals why vaccination site matters for immune response

Associate Professors Clare Stirzaker and David Croucher

Clare_Stirzaker_and_David_Croucher_Garvan_Institute.jpg

Cancer Council NSW grants will support innovative approaches to monitoring breast cancer recurrence and improving treatment effectiveness for high-risk neuroblastoma.

Breast cancer blood test and childhood cancer projects given the green light

Ira_Deveson_Garvan_Institute

A major new Garvan-led research project will develop advanced DNA analysis methods to provide a more detailed picture of the human genome, improving access to the benefits of genetic medicine for diverse populations.

Research to unlock life-changing benefits from advanced DNA analysis

Ira_Deveson_Garvan_Institute-2.jpg

Dr Ira Deveson will receive the Ruth Stephens Gani Medal at the 2025 Science at the Shine Dome event, in recognition of his contributions to clinical genomics and bioinformatics. 

Australian Academy of Science honours Garvan genomics researcher

Maté Biro Garvan Institute.jpg

Associate Professor Maté Biro brings specialised expertise in how immune cells interact with tumours to the Institute’s Cancer Ecosystems Program.


Garvan appoints leading expert in cancer-immune interactions

Associate Professors Owen Siggs and Jodie Ingles are leading the Genomics of Rare Disease Registry

Jodie_Ingles_and_Owen_Siggs_Garvan_Institute-2.jpg

Sydney researchers are recruiting for a study aimed at improving diagnosis, treatment and support for an estimated two million people who live with rare genetic diseases in Australia alone.

Recruiting now: study to uncover genetic cause of rare diseases

Sophie Hespe
and Associate Professor Jodie Ingles

Jodie_Sophie_Garvan-Institute.jpg

Garvan researchers update guidelines on which genes should – and which should not – be included in genetic testing for patients with hypertrophic cardiomyopathy.

Researchers refine genetic test panel for inherited cardiomyopathy

Dr-Shona-Ritchie_Garvan-Institute.jpg

Dr Shona Ritchie has received Cancer Institute NSW funding to explore how a cholesterol-regulating medication could make existing chemotherapies more effective against pancreatic cancer.

Garvan researcher to investigate cholesterol-lowering drug for pancreatic cancer treatment

221020_Katherine-Samaras_Garvan-Institute

A commonly used treatment for diabetes may hold the key to slowing cognitive decline to prevent dementia. This Phase 3 clinical trial is seeking participants.

Clinical trial will test drug treatment for prevention of dementia

Professor Paul Timpson, Dr Cecilia Chambers and Dr David Herrmann

Professor-Paul-Timpson_Dr-Cecilia-Chambers_Dr-David-Herrmann_Garvan-Institute.jpg

Scientists identify a molecule that fuels pancreatic cancer spread to the liver, opening new avenues for treatment.

A metabolism switch that could help stop the spread of pancreatic cancer

Dr Brooke Pereira with her Excellency the Honourable Ms Sam Mostyn AC at the Fulbright Gala

Brooke-Pereira-Fulbright-Gala-Garvan-Institute.jpg

Garvan’s Dr Brooke Pereira has been awarded the prestigious Fulbright Scholarship to embark on an exchange to the US, where she will investigate new therapy targets for pancreatic cancer.

Dr Brooke Pereira awarded Fulbright Scholarship

Clockwise from top left: Dr Kylie James, Dr Curtis Cai, Dr Ruebena Dawes, Dr Etienne Masle-Farquhar and Dr Drew Neavin

Kylie-James-Curtis-Cai-Ruebena-Dawes-Etienne-Masle-Farquhar-Drew-Neavin-v3.jpg

National Health and Medical Research Council backs five Garvan scientists to pursue solutions for complex diseases affecting millions of Australians.

Next wave of medical research backed by national grants

Seyhan-Yazar-Garvan-Institute

A new Garvan study will investigate how to spot multiple sclerosis before symptoms appear, to help prevent long-term nerve damage.

New research to target hidden signs of MS

Dr Alexandra Butters and Associate Professor Jodie Ingles 

jodei-and-alex-composite-v2.jpg

A case report of a misclassified cardiomyopathy gene variant highlights the need for more diversity in genomics.

Australian researchers call for greater diversity in genomics

Ankur-Sharma-Garvan-Institute

An international research project has been greenlit under the NHMRC ASPIRE program, bringing together Australian and Japanese experts to create a detailed spatial map of cancer and its immune environment.

Major Australia-Japan cancer mapping project to guide precision medicine

Cindy-Ma-Geetha-Rao-Garvan-Institute

Study of an immune messenger offers fresh hope for patients with allergies, asthma and other immune disorders.

Immune ‘mystery molecule’ points to potential targets for allergies and other immune conditions

Chris-Goodnow-Garvan-Institute

Landmark discoveries about the immune system’s protective mechanisms earn global recognition for Garvan researcher.

Professor Christopher Goodnow awarded prestigious Crafoord Prize

Professor Chris Goodnow, Dr Clara Young and Dr Dan Suan

Chris-Goodnow-Clara-Young-Dan-Suan-Garvan-Institute.jpg

Garvan researchers have uncovered how chronic hepatitis C infection leads to autoimmune disease, which opens new paths for treatments.

‘Perfect storm’ of mutations drives infection-triggered autoimmune disease

Clockwise from left: Dr Drew Neavin, Dr Brooke Pereira, Dr Andre Reis, Dr Kendelle Murphy, Dr Marcia Munoz and Professor Daniel Christ

_NHMRC-Ideas-and-Development-Grants_banner.jpg

Six research teams at Garvan have been awarded significant funding to pursue solutions across antibody therapy, inflammatory bowel disease, pancreatic cancer, bipolar disorder and genomic medicine.

Garvan research boosted by NHMRC Ideas and Development Grants

kimberley-bracelet1680x1120.png

In August, we celebrate a significant milestone with Paspaley reaching $2 million in donations in support of Garvan’s cancer research. 

Paspaley’s jewellery with purpose

antibody-illustration-Garvan-Institute

New insights into how checkpoint inhibitors affect the immune system could improve cancer treatment.

Study reveals cause of common cancer immunotherapy side effect

Brooke_Pereira_Kendelle_Murphy_Garvan_Institute

The projects are targeting the dense scarring around pancreatic tumours that hinders the success of chemotherapy.

Pancreatic cancer projects funded at Garvan to investigate new strategies for therapy

Professor Stuart Tangye and Dr Ira Deveson

Stuart-Tangye-Ira-Deveson-Garvan-Institute

Professor Stuart Tangye and Dr Ira Deveson have been recognised for their outstanding contributions to immunology and clinical genomics.

Garvan researchers honoured with NSW Premier’s Prizes

Professor-Stuart-Tangye-3_Garvan-Institute.jpg

Professor Stuart Tangye’s work advancing rare immune disease research has received national recognition.

Garvan immunologist awarded 2024 Eureka Prize

Professor Daniel MacArthur speaking at SXSW Sydney

SXSW_Daniel_MacArthur_Garvan-Institute.jpg

Researchers aim to collect genetic data from 10,000 diverse Australians to improve disease prediction, diagnosis and treatment for people from under-represented backgrounds.

Diverse Australians invited to shape future of genomic medicine

Dr David Herrmann and Professor Paul Timpson

Paul-Timpson-and-David-Hermann_Garvan-Institute.jpg

A new trial will test whether ‘priming’ pancreatic cancer can make it more susceptible to chemotherapy.

Pancreatic cancer clinical trial to test new approach to treatment

Peter_Croucher_Garvan_Institute

Professor Peter Croucher has been honoured with an award from the American Society for Bone and Mineral Research.

Prestigious bone research award for Professor Peter Croucher

190618_Alex-Swarbrick_Garvan-Institute

Research into predictive biomarkers at Garvan has been recognised internationally with a significant funding boost.

International fellowship for Garvan breast cancer researcher

Liz-Caldon-Garvan-Institute

By analysing more than 80 clinical trials, researchers at Garvan have identified genetic tests that predict which cancer patients are likely to benefit from PARP inhibitors in combination with chemotherapy.

Predicting cancer patient response to PARP inhibitors

Deborah_Burnett_Garvan_Institute

Prestigious fellowship recognises Dr Burnett’s exceptional research in immunology.

L’Oréal-UNESCO Fellowship awarded to Garvan’s Dr Deborah Burnett

Deborah-Burnett.jpg

The 2023 NSW Premier’s Prize for Early Career Researcher of the Year (Biological Sciences) recognises Garvan’s Dr Deborah Burnett.

Dr Deborah Burnett honoured with NSW Premier’s Prize

Professor Paul Timpson and Associate Professor Marina Pajic at the Garvan Institute

Paul-Timpson-Marina-Pajic-Garvan-Institute

Garvan researchers will contribute to multi-institutional collaborations to overcome current challenges in cancer treatment.

Researchers unite for major national cancer projects

Scott_Perkins_Garvan_Chair_Board.jpg

We are pleased to announce the appointment of Mr Scott Perkins as Chair of Garvan's Board of Directors. 

New Chair for Garvan Institute of Medical Research

Ira_Deveson_and_Andre_Reis_Garvan_Institute

New research provides the most comprehensive picture to date of the genomic diversity within and between First Nations communities across Australia.

Unique diversity of Indigenous Australians revealed by next-generation genomics

Dr Joanna Achinger-Kawecka and Dr David Herrmann

Joanna-Achinger-Kawecka_David Herrmann

Garvan researchers investigating the ‘ecosystems’ of breast and pancreatic cancer have been awarded Ideas Grants from the National Health and Medical Research Council.

Innovative cancer research projects awarded NHMRC funding

Professor Susan Clark, Professor Tri Phan, Associate Professor Elissa Deenick and Associate Professor Marina Pajic

Elissa-Deenick-Marina-Pajic-Susan-Clark-Tri-Phan

A significant funding boost will help Garvan’s cancer and immunology researchers pursue new directions and form collaborations.

Personalised medicine research projects backed by major grants

Professor Tri Phan, Dr Jennifer Massey and Associate Professor Elissa Deenick, leaders of the OCCAMS multiple sclerosis research consortium.

Tri-Phan_Jennifer-Massey_Elissa-Deenick_OCCAMS

Researchers and clinicians across Australia unite to develop better ways to detect, prevent and treat multiple sclerosis.

Sydney researchers to lead multiple sclerosis study

Dr Joanna Achinger-Kawecka, Professor Susan Clark and Associate Professor Clare Stirzaker

Composite_photo_.png

Garvan researchers have revealed a reason why endocrine resistance develops in breast cancers and how to potentially treat it in patients.

Epigenetic therapy shows promise for endocrine-resistant breast cancer

Professor Christopher Goodnow and Dr Tim Peters

immunity-break-story_Garvan-Institute-2.jpg

Researchers have identified a new genomic signature that controls whether the immune system’s specialised ‘killer’ T cells activate or stand down, revealing 100 potential new drug targets for cancer and autoimmune disease.

Immune ‘brake’ reveals drug targets for cancer and autoimmune disease

Dr Brooke Pereira (L) and Dr Kendelle Murphy (R)

Brooke-Pereira-and-Kendelle-Murphy_Garvan-Institute.jpeg

CINSW awards Early Career Fellowships to two Garvan cancer researchers.

Cancer Institute NSW funds early career research

220104_Thomas-Cox_Garvan-Institute

Garvan’s Associate Professor Thomas Cox has received funding to investigate a new treatment approach for pancreatic cancer.

A/Prof Thomas Cox awarded NHMRC Development Grant

Professor Mike Rogers and Dr Marcia Munoz

Mike-Rogers-and-Marcia-Munoz_Garvan-Institute.jpeg

Researchers have uncovered a mechanism by which bisphosphonates – a treatment commonly prescribed for osteoporosis – may help fight respiratory infections.

Common osteoporosis medication boosts immune response in lungs

Dr Deborah Burnett at the Garvan Institute

deborah-burnett_Garvan-Institute.jpeg

Dr Deborah Burnett outlines the pros and cons of variant-specific vaccines and the search for a universal COVID vaccine.

Will an Omicron-specific vaccine help control COVID? There’s one key problem

220128_Alex-Swarbrick_Garvan-Institute

Researchers at Garvan have identified a potential therapy that may improve how effectively chemotherapy targets neuroblastomas.

Research reveals approach to improve therapy for childhood cancer

Professor Leslie Burnett AM was among those recognised in the 2022 Australia Day Honours


220131_Leslie-Burnett-AM-Australia-Day-Honours_Garvan-Institute

For significant contributions to science, leadership, philanthropy and the arts.

Garvan community recognised in Australia Day Honours List

Dr Brooke Pereira and Professor Paul Timpson

brooke-Pereira-and-Paul-Timpson_Garvan-Institute.jpeg

PanKind foundation supports new study to improve immunotherapy outcomes in pancreatic cancer.

Funding boost to Garvan’s pancreatic cancer research

220303_Paul-Timpson_Garvan-Institute

A Garvan project to explore a potential new approach to treating fibrosis in breast cancer has been awarded a grant from the US Department of Defense.

Explore our research

Our impact

Our people

News and resources

About us

Support Us

News

Featured Article

Historic $25 million grant backs Garvan breast cancer research